Filter posts

FDA’s Dr. Theresa Mullin Addresses BIO Patient and Health Advocacy Summit

“So, Theresa, where did you grow up? Did you have any siblings?” asked Marc Boutin, …

Welcome to the 2017 BIO Patient and Health Advocacy Summit!

Patients are at the forefront of everything we do. Each year BIO brings the patient …

Oncology Innovation Has Produced Major Drop in Pediatric Cancer Deaths

One of the toughest parts of working in the biotechnology industry is the likelihood that …

ICYMI: Citizens Against Government Waste Speaks Out Against Waste in 340B Drug Discount Program

Writing this week for The Hill, Elizabeth Wright of Citizens Against Government Waste highlights an …

Insurer Shifting Blame for Rising Premiums

According to a new report from Chad Terhune with Kaiser Health News, insurance giant Anthem …

New Infographic: A Response to “A Better Deal” on Drug Pricing

The United States is the global leader in biomedical innovation, discovering more new cures than …

Biotech Industry Making Strides In Race to Beat Prostate Cancer

As CEO of a global organization, I’m often on the run. To maintain my stamina, …

JAMA Study Misses the Mark on Cancer R&D Costs & Profitability

Yesterday, JAMA Internal Medicine published a new paper purporting to estimate the R&D expense associated …

Expanded Access – It Continues to Make Headlines

The recent Senate passage of S. 204, the Trickett Wendler, Frank Mongiello, and Jordan McLinn …

ICYMI: Drug Pricing Bill Is Bad for Business, Patients

Researchers and biotech leaders continue to discover new cures and treatments that are making a …